V11294A is a novel PDE4 inhibitor. A single oral 300 mg dose of V11294A administered to healthy volunteers results in plasma concentrations adequate to inhibit activation of inflammatory cells ex vivo, which persists for at least 24 h without any adverse reactions
Molekulargewicht:
409.52
CAS Nummer:
[162278-10-6]
Formel:
C23H31N5O2
Target-Kategorie:
Others
T70362
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
